BrainChip Holdings Ltd. has confirmed the lapse of a significant number of equity-linked incentives, casting a spotlight on the company's...

Shares of Viromed Medical (VIROMED MEDICAL) continue to trade near their annual low at €5.20, despite the company receiving a...

While Nvidia continues to post staggering financial results, a persistent shadow of trade policy uncertainty hangs over the semiconductor giant....

The iShares MSCI World ETF (URTH) is navigating a period of intensified competition and impending structural change. As a core...

The data analytics firm Palantir continues to post impressive operational growth, yet on Wall Street, skepticism is mounting over its...

Despite reports of a multi-billion dollar budget for its next major title, Take-Two Interactive Software Inc. is seeing its stock...

The biotechnology firm ImmunityBio finds itself caught between significant operational progress and mounting regulatory scrutiny. A recent official warning from...

Pharmaceutical giant Eli Lilly is strategically expanding its empire beyond its blockbuster weight-loss drugs. In a series of moves totaling...

Amazon is passing on rising operational costs to the third-party merchants using its platform. Effective April 17, a new fuel...

The digital payments landscape is on the cusp of a profound transformation, and Visa is positioning itself at the center...